https://www.investorideas.com/RSS/feeds/Portals/Biotechnology.xml Investorideas.com newswire, breaking biotechnology and pharma news en-us C2000-2022 InvestorIdeas.com tm httpS://www.investorideas.com/banners/iilogo.gif https://www.investorideas.com/RSS/feeds/Portals/Biotechnology.xml info@investorideas.com (Dawn Van Zant) Medical tech stock Aethlon Medical, Inc. (NASDAQ: AEMD) is on the move with shares gaining over 13% and reaching a morning high of $2.09 following news the company engaged Maxim Group to evaluate strategic opportunities. https://www.investorideas.com/CO/AEMD/news/2026/03131-aethlon-aemd-stock-on-the-move.asp Fri, 13 Mar 2026 11:15:00 EST https://www.investorideas.com/CO/AEMD/news/2026/03131-aethlon-aemd-stock-on-the-move.asp Biotech Medical tech stock Aethlon Medical, Inc. (NASDAQ: AEMD) gains on news the company engaged Maxim Group LLC to evaluate strategic opportunities including partnerships, mergers and acquisitions. https://www.investorideas.com/CO/AEMD/news/2026/03122-aethlon-aemd-maxim-strategic-opportunities.asp Thu, 12 Mar 2026 12:00:00 EST https://www.investorideas.com/CO/AEMD/news/2026/03122-aethlon-aemd-maxim-strategic-opportunities.asp Biotech Medical tech stock Aethlon Medical, Inc. (NASDAQ: AEMD) announces it has engaged Maxim Group LLC as exclusive financial advisor to evaluate strategic opportunities including potential partnerships, mergers, acquisitions and other transactions. https://www.investorideas.com/CO/AEMD/news/2026/03121-aethlon-aemd-maxim-strategic-opportunities.asp Thu, 12 Mar 2026 09:20:00 EST https://www.investorideas.com/CO/AEMD/news/2026/03121-aethlon-aemd-maxim-strategic-opportunities.asp Biotech Longeveron Inc. (NASDAQ: LGVN) tops Nasdaq percentage gainers list, trading up 47% on news of a private placement of up to $30 million to fund its Phase 2b ELPIS II clinical trial for HLHS through Q4 2026. https://www.investorideas.com/news/2026/biotech/03101-longeveron-lgvn-nasdaq-top-gainer-30-million-private-placement.asp Tue, 10 Mar 2026 11:00:00 EST https://www.investorideas.com/news/2026/biotech/03101-longeveron-lgvn-nasdaq-top-gainer-30-million-private-placement.asp Biotech Edesa Biotech (Nasdaq: EDSA) surges to Nasdaq top gainers after Phase 3 paridiprubart study shows 27% relative reduction in 28-day mortality across 278 patients, with consistent benefits in sepsis, acute kidney injury, and pneumonia cases. https://www.investorideas.com/news/2026/biotech/02241-edesa-biotech-edsa-phase-3-paridiprubart-positive-results-mortality-reduction.asp Tue, 24 Feb 2026 12:42:00 EST https://www.investorideas.com/news/2026/biotech/02241-edesa-biotech-edsa-phase-3-paridiprubart-positive-results-mortality-reduction.asp Biotech Nektar Therapeutics (Nasdaq: NKTR) surged onto the Nasdaq top gainers list after reporting positive Phase 2b results from its REZOLVE-AD study of rezpegaldesleukin in moderate-to-severe atopic dermatitis, demonstrating durable responses, improved disease control, and strong long-term efficacy through 52 weeks. https://www.investorideas.com/news/2026/biotech/02101-biotech-stock-nektar-therapeutics-nktr-top-gainer-rezolve-ad-study.asp Tue, 10 Feb 2026 12:52:00 EST https://www.investorideas.com/news/2026/biotech/02101-biotech-stock-nektar-therapeutics-nktr-top-gainer-rezolve-ad-study.asp Biotech February 4, 2026 (Investorideas.com Newswire) Aethlon Medical Inc Nasdaq AEMD will report fiscal Q3 financial results and host a conference call on February 12 2026 to discuss results and updates. https://www.investorideas.com/CO/AEMD/news/2026/020426-aethlon-medical-aemd-q3-financial-results-conference-call.asp Wed, 04 Feb 2026 09:38:00 EST https://www.investorideas.com/CO/AEMD/news/2026/020426-aethlon-medical-aemd-q3-financial-results-conference-call.asp Biotech December 2, 2025 (Investorideas.com Newswire) Aethlon Medical (NASDAQ: AEMD) publishes new Hemopurifier data showing GNA resin binds Long COVID extracellular vesicles and reduces inflammatory microRNAs. https://www.investorideas.com/CO/AEMD/news/2025/12021-aethlon-medical-aemd-hemopurifier-long-covid-preclinical-data-2025.asp Tue, 02 Dec 2025 09:46:00 EST https://www.investorideas.com/CO/AEMD/news/2025/12021-aethlon-medical-aemd-hemopurifier-long-covid-preclinical-data-2025.asp Biotech November 17, 2025 (Investorideas.com Newswire) Actinium Pharmaceuticals, Novartis, Lila Biologics, Eli Lilly, and AdvanCell advance targeted radiotherapy and radioligand therapy innovations as global cancer treatment demand surges, driving major investment, partnerships, and next-generation oncology pipeline growth. https://www.investorideas.com/news/2025/biotech/11171-actinium-atnm-cancer-radiotherapy-market-growth-biotech-stock-analysis.asp Mon, 17 Nov 2025 10:10:00 EST https://www.investorideas.com/news/2025/biotech/11171-actinium-atnm-cancer-radiotherapy-market-growth-biotech-stock-analysis.asp Biotech October 27, 2025 (Investorideas.com Newswire) Co-Diagnostics, Inc. (Nasdaq: CODX) surges over 142%, making the Nasdaq top gainers list after announcing a Saudi-based joint venture, CoMira Diagnostics, with Arabian Eagle Manufacturing. https://www.investorideas.com/news/2025/biotech/10271-co-diagnostics-codx-saudi-comira-diagnostics-joint-venture.asp Mon, 27 Oct 2025 11:00:00 EST https://www.investorideas.com/news/2025/biotech/10271-co-diagnostics-codx-saudi-comira-diagnostics-joint-venture.asp Biotech October 23, 2025 (Investorideas.com Newswire) Scienture Holdings (NASDAQ: SCNX) jumps 129% on Nasdaq top gainers list after announcing commercial sales and first Arbli oral suspension orders for hypertension. https://www.investorideas.com/news/2025/biotech/10231-scienture-holdings-scnx-nasdaq-gainer-arbli-commercial-sales.asp Thu, 23 Oct 2025 11:35:00 EST https://www.investorideas.com/news/2025/biotech/10231-scienture-holdings-scnx-nasdaq-gainer-arbli-commercial-sales.asp Biotech October 17, 2025 (Investorideas.com Newswire) Artiva Biotherapeutics (NASDAQ: ARTV) surges over 100% after the FDA grants Fast Track Designation to AlloNK (AB-101) for refractory rheumatoid arthritis. https://www.investorideas.com/news/2025/biotech/10172-artiva-biotherapeutics-fda-fast-track-allonk-refractory-ra.asp Fri, 17 Oct 2025 11:50:00 EST https://www.investorideas.com/news/2025/biotech/10172-artiva-biotherapeutics-fda-fast-track-allonk-refractory-ra.asp Biotech October 17, 2025 (Investorideas.com Newswire) Rani Therapeutics (NASDAQ: RANI) surges over 240% after announcing a $1.085 billion collaboration with Chugai Pharmaceutical to develop oral biologics using its RaniPill technology for rare diseases and immunologic treatments. https://www.investorideas.com/news/2025/biotech/10171-rani-therapeutics-nasdaq-rani-soars-on-1-billion-chugai-pharma-collaboration.asp Fri, 17 Oct 2025 10:40:00 EST https://www.investorideas.com/news/2025/biotech/10171-rani-therapeutics-nasdaq-rani-soars-on-1-billion-chugai-pharma-collaboration.asp Biotech October 15, 2025 (Investorideas.com Newswire) Genprex (NASDAQ: GNPX) surges over 200% on positive preclinical data for Reqorsa gene therapy in ALK-positive non-small cell lung cancer. https://www.investorideas.com/news/2025/biotech/10151-gene-therapy-stock-genprex-gnpx-soars-on-positive-preclinical-data.asp Wed, 15 Oct 2025 10:45:00 EST https://www.investorideas.com/news/2025/biotech/10151-gene-therapy-stock-genprex-gnpx-soars-on-positive-preclinical-data.asp Biotech October 08, 2025 (Investorideas.com Newswire) Biotech and medical technology stocks are making major moves following new clinical trial updates. Aethlon Medical (Nasdaq: AEMD), Envoy Medical (Nasdaq: COCH), Soligenix (Nasdaq: SNGX), and MBX Biosciences (Nasdaq: MBX) release promising trial data showcasing innovation in cancer, hearing loss, rare diseases, and endocrine therapy. https://www.investorideas.com/CO/AEMD/news/2025/10081-biotech-medical-tech-stocks-clinical-trial-updates-aemd-coch-sngx-mbx.asp Wed, 08 Oct 2025 08:41:00 EST https://www.investorideas.com/CO/AEMD/news/2025/10081-biotech-medical-tech-stocks-clinical-trial-updates-aemd-coch-sngx-mbx.asp Biotech October 07, 2025 (Investorideas.com Newswire) Breaking Medical Tech News - Aethlon Medical, Inc. (Nasdaq: AEMD) today provided observations on the preliminary changes in extracellular vesicle (EV), microRNA and lymphocyte counts in the first patient cohort in its ongoing oncology clinical trial in Australia. https://www.investorideas.com/CO/AEMD/news/2025/10071-aethlon-medical-hemopurifier-oncology-trial-update-aemd.asp Tue, 07 Oct 2025 08:45:00 EST https://www.investorideas.com/CO/AEMD/news/2025/10071-aethlon-medical-hemopurifier-oncology-trial-update-aemd.asp Biotech September 4, 2025 (Investorideas.com Newswire) Investorideas.com (Newswire), a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking at innovation and the importance of IP in medtech, featuring Aethlon Medical, Inc.(Nasdaq:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. https://www.investorideas.com/CO/AEMD/news/2025/09041medtech-stocks-ip-portfolio-market-leaders.asp Thu, 04 Sep 2025 08:08:00 EST https://www.investorideas.com/CO/AEMD/news/2025/09041medtech-stocks-ip-portfolio-market-leaders.asp Biotech September 3, 2025 (Investorideas.com Newswire) Aethlon Medical (Nasdaq: AEMD) announces issuance of U.S. (12,409,260) and European (EP 4136453) patents for its Hemopurifier to treat Long COVID and COVID-19-associated coagulopathy (CAC). https://www.investorideas.com/CO/AEMD/news/2025/09031aethlon-medical-hemopurifier-long-covid-cac-patents-aemd.asp Wed, 03 Sep 2025 07:45:00 EST https://www.investorideas.com/CO/AEMD/news/2025/09031aethlon-medical-hemopurifier-long-covid-cac-patents-aemd.asp Biotech August 13, 2025 (www.investorideas.com Newswire) Aethlon Medical (Nasdaq: AEMD) reports fiscal Q1 2025 results with $3.8M cash, 32% lower operating expenses, and clinical trial updates. Conference call scheduled for August 13, 2025 at 4:30 p.m. ET. https://www.investorideas.com/CO/AEMD/news/2025/08131aethlon-medical-aemd-q1-2025-financial-results-conference-call.asp Wed, 13 Aug 2025 16:15:00 EST https://www.investorideas.com/CO/AEMD/news/2025/08131aethlon-medical-aemd-q1-2025-financial-results-conference-call.asp Biotech August 5, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal first quarter ended June 30, 2025, at 4:15 p.m. ET on Wednesday, August 13, 2025. https://www.investorideas.com/CO/AEMD/news/2025/08051aethlon-medical-inc-aemd-first-quarter-financial-results.asp Tue, 05 Aug 2025 10:05:00 EST https://www.investorideas.com/CO/AEMD/news/2025/08051aethlon-medical-inc-aemd-first-quarter-financial-results.asp Biotech SAN DIEGO - July 15, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier, an extracorporeal device for Oncology and other indications, today announced that the independent Data Safety Monitoring Board (DSMB) overseeing its ongoing clinical trial AEMD-2022-06 has completed its scheduled safety review and recommended advancing to the next patient cohort without modification. https://www.investorideas.com/news/2025/07151AEMD-Positive-Data-Safety-Monitoring-Board-Review.asp Tue, 15 Jul 2025 09:40:00 EST https://www.investorideas.com/news/2025/07151AEMD-Positive-Data-Safety-Monitoring-Board-Review.asp Biotech SAN DIEGO - June 27, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, reported financial results for its fiscal fourth quarter ended March 31, 2025, and provided an update on recent developments. https://www.investorideas.com/news/2025/06271AEMD-Q4-Financial-Results.asp Fri, 27 Jun 2025 09:20:00 EST https://www.investorideas.com/news/2025/06271AEMD-Q4-Financial-Results.asp Biotech SAN DIEGO - June 18, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced a significant milestone: the treatment of the second patient with the Hemopurifier in its Australian safety, feasibility and dose-finding clinical trial of the Hemopurifier. https://www.investorideas.com/news/2025/06181AEMD-Treats-Second-Patient-in-Australian-Hemopurifier-Cancer-Trial.asp Wed, 18 Jun 2025 09:20:00 EST https://www.investorideas.com/news/2025/06181AEMD-Treats-Second-Patient-in-Australian-Hemopurifier-Cancer-Trial.asp Biotech SAN DIEGO - June 9, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that an abstract has been accepted for poster presentation at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes being held at Eldorado Hotel and Spa, Santa Fe, NM, United States, August 10-13,2025 https://www.investorideas.com/news/2025/06091AEMD-Pre-Clinical-Data-on-Long-COVID-and-Post-Acute-Infection-Syndromes.asp Mon, 09 Jun 2025 09:10:00 EST https://www.investorideas.com/news/2025/06091AEMD-Pre-Clinical-Data-on-Long-COVID-and-Post-Acute-Infection-Syndromes.asp Biotech SAN DIEGO - May 15, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the publication of a pre-clinical ex vivo study in pre-print vehicle bioRxiv, entitled, "Ex Vivo Removal of CD41 positive platelet microparticles from Plasma by a Medical Device containing a Galanthus nivalis agglutinin (GNA) affinity resin." https://www.investorideas.com/news/2025/05151AEMD-Hemopurifier-Remove-Platelet-Derived-Extracellular-Vesicles-from-Plasma.asp Thu, 15 May 2025 09:40:00 EST https://www.investorideas.com/news/2025/05151AEMD-Hemopurifier-Remove-Platelet-Derived-Extracellular-Vesicles-from-Plasma.asp Biotech April 15, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Mural Oncology (Nasdaq: MURA), a clinical-stage immuno-oncology company. https://www.investorideas.com/news/2025/biotech/04151Mural-Oncology-MURA.asp Tue, 15 Apr 2025 10:50:00 EST https://www.investorideas.com/news/2025/biotech/04151Mural-Oncology-MURA.asp Biotech April 2, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Sunshine Biopharma Inc. (NASDAQ:SBFM) a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals. https://www.investorideas.com/news/2025/biotech/04022Sunshine-Biopharma-SBFM.asp Wed, 02 Apr 2025 10:50:00 EST https://www.investorideas.com/news/2025/biotech/04022Sunshine-Biopharma-SBFM.asp Biotech April 2, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases https://www.investorideas.com/news/2025/biotech/04021bioAffinity-Technologies-BIAF.asp Wed, 02 Apr 2025 09:10:00 EST https://www.investorideas.com/news/2025/biotech/04021bioAffinity-Technologies-BIAF.asp Biotech March 28, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Dermata Therapeutics, Inc. (Nasdaq: DRMA, DRMAW), a late-stage biotechnology company focusing on the treatment of medical skin diseases and aesthetic applications. https://www.investorideas.com/news/2025/biotech/03281Dermata-Therapeutics-DRMA.asp Fri, 28 Mar 2025 09:10:00 EST https://www.investorideas.com/news/2025/biotech/03281Dermata-Therapeutics-DRMA.asp Biotech March 21, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers,ntral nervous system (CNS) cancers. https://www.investorideas.com/news/2025/biotech/03211Plus-Therapeutics-PSTV.asp Fri, 21 Mar 2025 09:30:00 EST https://www.investorideas.com/news/2025/biotech/03211Plus-Therapeutics-PSTV.asp Biotech March 11, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for 2seventy bio, Inc. (Nasdaq: TSVT). https://www.investorideas.com/news/2025/biotech/031112seventy-bio-TSVT.asp Tue, 11 Mar 2025 15:30:00 EST https://www.investorideas.com/news/2025/biotech/031112seventy-bio-TSVT.asp Biotech SAN DIEGO - March 10, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases and for use in organ transplantation, today announced the publication of a pre-clinical study in the peer-reviewed journal Transplant Immunology on February 28, 2025, entitled, "A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneys." https://www.investorideas.com/news/2025/03101AEMD-Preclinical-Data-on-Hemopurifier-in-Transplant-Immunology-Journal.asp Mon, 10 Mar 2025 09:30:00 EST https://www.investorideas.com/news/2025/03101AEMD-Preclinical-Data-on-Hemopurifier-in-Transplant-Immunology-Journal.asp Biotech March 6, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers. https://www.investorideas.com/news/2025/biotech/03061Plus-Therapeutics-PSTV.asp Thu, 06 Mar 2025 15:50:00 EST https://www.investorideas.com/news/2025/biotech/03061Plus-Therapeutics-PSTV.asp Biotech February 28, 2025 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks added to the biotech stock directory. https://www.investorideas.com/news/2025/main/02281Stocks.asp Fri, 28 Feb 2025 09:10:00 EST https://www.investorideas.com/news/2025/main/02281Stocks.asp Investment February 26, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Enveric Biosciences (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. https://www.investorideas.com/news/2025/biotech/02261Enveric-Biosciences-ENVB.asp Wed, 26 Feb 2025 14:50:00 EST https://www.investorideas.com/news/2025/biotech/02261Enveric-Biosciences-ENVB.asp Biotech February 25, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) https://www.investorideas.com/news/2025/biotech/02251Organovo-Holdings-ONVO.asp Tue, 25 Feb 2025 15:00:00 EST https://www.investorideas.com/news/2025/biotech/02251Organovo-Holdings-ONVO.asp Biotech February 24, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. https://www.investorideas.com/news/2025/biotech/02241PepGen-PEPG.asp Mon, 24 Feb 2025 13:40:00 EST https://www.investorideas.com/news/2025/biotech/02241PepGen-PEPG.asp Biotech SAN DIEGO - February 13, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 19, 2025. https://www.investorideas.com/news/2025/02131AEMD-Present-at-the-Emerging-Growth-Conference.asp Thu, 13 Feb 2025 11:30:00 EST https://www.investorideas.com/news/2025/02131AEMD-Present-at-the-Emerging-Growth-Conference.asp Biotech SAN DIEGO - February 12, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2024 and provided an update on recent developments. https://www.investorideas.com/news/2025/02121AEMD-Financial-Results-for-Q3-and-Corporate-Update.asp Wed, 12 Feb 2025 16:30:00 EST https://www.investorideas.com/news/2025/02121AEMD-Financial-Results-for-Q3-and-Corporate-Update.asp Biotech February 12, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Tivic Health Systems, Inc., (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health. https://www.investorideas.com/news/2025/biotech/02121Tivic-Health-Systems-TIVC.asp Wed, 12 Feb 2025 15:30:00 EST https://www.investorideas.com/news/2025/biotech/02121Tivic-Health-Systems-TIVC.asp Biotech SAN DIEGO - February 5, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2024, at 4:15 p.m. ET on Wednesday, February 12, 2025. https://www.investorideas.com/news/2025/02051AEMD-Fiscal-Q3-Financial-Results-Conference-Call.asp Wed, 05 Feb 2025 09:10:00 EST https://www.investorideas.com/news/2025/02051AEMD-Fiscal-Q3-Financial-Results-Conference-Call.asp Biotech February 3, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. https://www.investorideas.com/news/2025/biotech/02031Invivyd-IVVD.asp Mon, 03 Feb 2025 15:40:00 EST https://www.investorideas.com/news/2025/biotech/02031Invivyd-IVVD.asp Biotech January 29, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech and medical tech stocks reports on trading and news for Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. https://www.investorideas.com/news/2025/biotech/01291Medical-Therapeutic-Stock-AEMD.asp Wed, 29 Jan 2025 11:40:00 EST https://www.investorideas.com/news/2025/biotech/01291Medical-Therapeutic-Stock-AEMD.asp Biotech SAN DIEGO - January 29, 2025 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced a significant milestone: the treatment of the first patient with the Hemopurifier in its Australian safety, feasibility and dose-finding clinical trial of the Hemopurifier. https://www.investorideas.com/news/2025/01291AEMD-Treats-First-Patient-in-Australian-Hemopurifier-Cancer-Trial.asp Wed, 29 Jan 2025 09:30:00 EST https://www.investorideas.com/news/2025/01291AEMD-Treats-First-Patient-in-Australian-Hemopurifier-Cancer-Trial.asp Biotech January 17, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech and medical stocks reports on trading and news for Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology. https://www.investorideas.com/news/2025/biotech/01171Healthcare-BDMD.asp Fri, 17 Jan 2025 14:40:00 EST https://www.investorideas.com/news/2025/biotech/01171Healthcare-BDMD.asp Biotech January 16, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech and medical stocks reports on trading and news for Biomerica, Inc.(Nasdaq: BMRA), a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. https://www.investorideas.com/news/2025/biotech/01161Biomedical-Stock-BMRA.asp Thu, 16 Jan 2025 14:30:00 EST https://www.investorideas.com/news/2025/biotech/01161Biomedical-Stock-BMRA.asp Biotech January 6, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech and psycadelic stocks reports on trading and news for SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system. https://www.investorideas.com/news/2025/biotech/01061SciSparc-SPRC.asp Mon, 06 Jan 2025 15:40:00 EST https://www.investorideas.com/news/2025/biotech/01061SciSparc-SPRC.asp Biotech December 31, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech and medical tech stocks reports on trading and news for Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. https://www.investorideas.com/news/2024/biotech/12311Medical-Therapeutic-Stock-AEMD.asp Tue, 31 Dec 2024 11:40:00 EST https://www.investorideas.com/news/2024/biotech/12311Medical-Therapeutic-Stock-AEMD.asp Biotech December 27, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Quantum-Si Incorporated (Nasdaq: QSI), The Protein Sequencing Company https://www.investorideas.com/news/2024/biotech/12271Quantum-Si-Incorporated-QSI.asp Fri, 27 Dec 2024 12:40:00 EST https://www.investorideas.com/news/2024/biotech/12271Quantum-Si-Incorporated-QSI.asp Biotech December 20, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech and medical tech stocks reports on trading and news for Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. https://www.investorideas.com/news/2024/biotech/12201AEMD-Hemopurifier-Bird-Flu-Update.asp Fri, 20 Dec 2024 11:20:00 EST https://www.investorideas.com/news/2024/biotech/12201AEMD-Hemopurifier-Bird-Flu-Update.asp Biotech SAN DIEGO - December 20, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today provided a statement of its investigational medical device with respect to H5N1 avian influenza "Bird Flu." https://www.investorideas.com/news/2024/12201AEMD-Hemopurifier-H5N1-Bird-Flu.asp Fri, 20 Dec 2024 09:10:00 EST https://www.investorideas.com/news/2024/12201AEMD-Hemopurifier-H5N1-Bird-Flu.asp Biotech December 11, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer https://www.investorideas.com/news/2024/biotech/12112Candel-Therapeutics-CADL.asp Wed, 11 Dec 2024 14:10:00 EST https://www.investorideas.com/news/2024/biotech/12112Candel-Therapeutics-CADL.asp Biotech November 26, 2024 (Investorideas.com Newswire) The common shares of Onco-Innovations Limited have been approved for listing on the CSE. https://www.investorideas.com/news/2024/biotech/11262NewList-CSE-ONCO.asp Tue, 26 Nov 2024 15:30:00 EST https://www.investorideas.com/news/2024/biotech/11262NewList-CSE-ONCO.asp Biotech November 26, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer, autoimmune and rare diseases. https://www.investorideas.com/news/2024/biotech/11261Poseida-Therapeutics-PSTX.asp Tue, 26 Nov 2024 14:10:00 EST https://www.investorideas.com/news/2024/biotech/11261Poseida-Therapeutics-PSTX.asp Biotech November 18, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for HCW Biologics Inc. (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases. https://www.investorideas.com/news/2024/biotech/11181HCW-Biologics-HCWB.asp Mon, 18 Nov 2024 14:20:00 EST https://www.investorideas.com/news/2024/biotech/11181HCW-Biologics-HCWB.asp Biotech November 15, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news for CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics augmented with phagocytic mechanisms derived from the innate arm of the immune system. https://www.investorideas.com/news/2024/biotech/11151CERo-Therapeutics-Holdings.asp Fri, 15 Nov 2024 14:40:00 EST https://www.investorideas.com/news/2024/biotech/11151CERo-Therapeutics-Holdings.asp Biotech November 14, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases a news snapshot from stocks in the sector looking at the advancement of treatments for solid tumors as global cancer incidence rates rise. https://www.investorideas.com/news/2024/biotech/11141AEMD-Cancer-Treatments.asp Thu, 14 Nov 2024 09:10:00 EST https://www.investorideas.com/news/2024/biotech/11141AEMD-Cancer-Treatments.asp Biotech SAN DIEGO - November 13, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal second quarter ended September 30, 2024 and provided an update on recent developments. https://www.investorideas.com/news/2024/11131AEMD-Fiscal-Second-Quarter.asp Wed, 13 Nov 2024 16:30:00 EST https://www.investorideas.com/news/2024/11131AEMD-Fiscal-Second-Quarter.asp Biotech